| Trial ID: | L6628 |
| Source ID: | NCT00684528
|
| Associated Drug: |
Metformin 1500 Mg Daily
|
| Title: |
A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: Metformin 1500 mg daily|DRUG: Metformin + Janufer (Janumet)
|
| Outcome Measures: |
Primary: The efficacy and safety of community based study in diabetic patients, comparing Metformin to Metformin + Janufer., 54 weeks|The efficacy and safety of Metformin VS Metformin + Janufer in the community setting, 2010 |
|
| Sponsor/Collaborators: |
Sponsor: Meir Medical Center | Collaborators: Clalit Health Services
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
1000
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-06
|
| Completion Date: |
2012-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-03-19
|
| Locations: |
Clalit Health services center, Tel Aviv, 62098, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00684528
|
